Foxf2-flox Mouse
Common Name
Foxf2-flox
제품 ID
S-CKO-02446
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-14238-Foxf2-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Foxf2-flox Mouse (카탈로그 번호 S-CKO-02446)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Foxf2-flox
품종 계통계통 ID
CKOCMP-14238-Foxf2-B6J-VA
유전자명
제품 ID
S-CKO-02446
유전자 별칭
LUN, Fkh20, FREAC2
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 13
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000042054
NCBI 전사체 ID
NM_010225
타겟 영역
Exon 1
유효 영역 크기
~1.4 kb
유전자 연구 개요
Foxf2, a member of the forkhead box transcription factors, serves as a transcriptional regulator. It plays crucial roles in embryonic development, metabolism, and is associated with common diseases like stroke and gastroparesis. In embryonic development, it may affect the expression of organ-specific genes to modulate organogenesis. It is also involved in various signal pathways, such as the Wnt/β-catenin pathway [1].
In prostate cancer, increasing prostatic stromal Foxf2 suppresses tumor growth and metastasis by enhancing antitumor immunity, as it attenuates the CAF phenotype and downregulates Cxcl5 [2]. In breast cancer, FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/β-catenin pathway, activating the pathway in luminal cells but repressing it in basal-like cells [3]. In bone-related processes, Foxf2 represses bone formation via the Wnt2b/β-catenin signaling. Osteoprogenitor-specific Foxf2 knockout mice show a high bone mass phenotype due to increased bone formation [4]. In esophageal squamous cell carcinoma, overexpression of FOXF2 inhibits cell proliferation and M2 polarization of tumor-associated macrophages by modulating the RNF144A-FTO axis [5]. In breast cancer bone metastasis, FOXF2 reprograms cancer cells into an osteomimetic phenotype by transactivating the BMP4/SMAD1 signaling pathway and bone-related genes [6]. In cochlear development, FOXF2 is required, as shown by a human variant associated with hearing loss and mouse knockout models having shortened and malformed cochleae [7]. In palate development, Foxf2 controls palatal shelf morphogenesis through regulating multiple transcription factors and extracellular matrix components, as identified by RNA-seq and ChIP-seq in mouse models [8].
In conclusion, Foxf2 is essential for embryonic development, organogenesis, and is involved in multiple disease-related processes. Gene knockout and conditional knockout mouse models have been instrumental in revealing its role in cancer progression, bone formation, cochlear and palate development. These findings provide valuable insights into the pathogenesis of related diseases and potential therapeutic targets.
References:
1. He, Weihan, Kang, Yuanbo, Zhu, Wei, Ren, Caiping, Guo, Weihua. 2020. FOXF2 acts as a crucial molecule in tumours and embryonic development. In Cell death & disease, 11, 424. doi:10.1038/s41419-020-2604-z. https://pubmed.ncbi.nlm.nih.gov/32503970/
2. Jia, Deyong, Zhou, Zhicheng, Kwon, Oh-Joon, Creighton, Chad J, Xin, Li. 2022. Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity. In Nature communications, 13, 6828. doi:10.1038/s41467-022-34665-z. https://pubmed.ncbi.nlm.nih.gov/36369237/
3. Zhang, Xiao, Zhang, Rui, Hou, Chen, Zhai, Qiong-Li, Feng, Yu-Mei. 2022. FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway. In The Journal of biological chemistry, 298, 102082. doi:10.1016/j.jbc.2022.102082. https://pubmed.ncbi.nlm.nih.gov/35660418/
4. Tanaka, Tomoyuki, Takahashi, Akira, Kobayashi, Yutaka, Carlsson, Peter, Inose, Hiroyuki. 2022. Foxf2 represses bone formation via Wnt2b/β-catenin signaling. In Experimental & molecular medicine, 54, 753-764. doi:10.1038/s12276-022-00779-z. https://pubmed.ncbi.nlm.nih.gov/35668101/
5. Han, Tianci, Tong, Wei, Xie, Junwei, Guo, Xiaoqi, Zhang, Liang. 2024. FOXF2 suppressed esophageal squamous cell carcinoma by reducing M2 TAMs via modulating RNF144A-FTO axis. In International immunopharmacology, 143, 113422. doi:10.1016/j.intimp.2024.113422. https://pubmed.ncbi.nlm.nih.gov/39447407/
6. Wang, Shuo, Li, Gui-Xi, Tan, Cong-Cong, Zhai, Qiong-Li, Feng, Yu-Mei. 2019. FOXF2 reprograms breast cancer cells into bone metastasis seeds. In Nature communications, 10, 2707. doi:10.1038/s41467-019-10379-7. https://pubmed.ncbi.nlm.nih.gov/31222004/
7. Bademci, Guney, Abad, Clemer, Incesulu, Armagan, Walz, Katherina, Tekin, Mustafa. . FOXF2 is required for cochlear development in humans and mice. In Human molecular genetics, 28, 1286-1297. doi:10.1093/hmg/ddy431. https://pubmed.ncbi.nlm.nih.gov/30561639/
8. Xu, J, Liu, H, Lan, Y, Park, J S, Jiang, R. 2020. Genome-wide Identification of Foxf2 Target Genes in Palate Development. In Journal of dental research, 99, 463-471. doi:10.1177/0022034520904018. https://pubmed.ncbi.nlm.nih.gov/32040930/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
